Search Results

Biological molecules in urine and gene-activity signals in blood can predict early in pregnancy which women develop preeclampsia, Stanford Medicine researchers found.

A technique developed at Stanford Medicine allows mice with diabetes to accept unmatched islet cells and durably restores blood sugar control without immunosuppression or graft-versus-host disease.

Disrupting a virus’s genome packaging can halt replication and jumpstart a natural immune response against subsequent exposures, a Stanford Medicine study finds.

The new issue of Stanford Medicine magazine features articles about the molecules that make us who we are and how understanding them can lead to medical discoveries and innovations.

Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.

A new study has identified a way that the immune system shoots down its own cells when their anti-viral activity threatens to become friendly fire. The finding could pave the way to new treatments for autoimmune diseases.

To treat diabetes directly, rather than manage its symptoms, doctors need a way to get drugs to cells that produce insulin. The key, Stanford researchers report, may be those cells’ affinity for zinc.

Fanconi anemia is a rare but deadly disease thought to be the result of aldehyde-induced DNA damage. Now, Stanford researchers are developing a test that could help kids with the disease and millions more with related conditions.

A circadian code controls the switch that produces fat cells, according to a new study by Stanford researchers.